Almeda Ventures

📢 NEWS: We’re thrilled to announce that TailorMed has secured $40M in funding! This empowers us to take our work to the next level, broadening access to care for millions of patients across the country. ✨Thanks to Windham Capital Partners and other visionary investors, we’re scaling our end-to-platform to unlock the full spectrum of medication access … from cost to care. A huge shoutout to our amazing team, clients, and partners for being part of our journey and helping us reach this milestone. We’re just getting started! 🚀 Read the press release to learn more about our exciting new chapter: https://lnkd.in/dDZB4eAp #digitalhealth #healthtech #investment #startup

 איך זה מרגיש 32 שנות ניסיון בשוק ההון הישראלי? זה לעשות אנאליזה למניה עם ניירות. כי עדיין לא פיתחו את האקסל!  פרק 7 בפודקאסט שלי “כסף חכם” – פודקאסט עם עצות פיננסיות מאנשים שהייתם רוצים בקאפ טייבל שלכם – עלה לאוויר! בפרק הזה אירחתי את צחי סולטן, יו״ר דיסקונט חיתום בעל שליטה במודיעין אנרגיה וג׳נרל פרטנר בביג טק ובאלמדה, לשיחה על ניהול סיכונים, החשיבות של הצוות שמוביל חברה, וטיפ “15 דקות של תהילה” למניות. צחי שיתף גם עצות פרקטיות למנפיקים על חשיבות הממשל התאגידי והתזמון בהנפקות.  שתפו איתנו בתגובות עצות פיננסיות שעשו שינוי עבורכם Tzahi Sultan Discount Capital #finance #stockmarket #investments

Another exciting milestone! 📢 Nurami Medical was granted the AMAR certificate for ArtiFascia, our dural repair graft. AMAR is the Israeli medical device regulatory approval by the Ministry of Health. This is the result of a challenging process and of an excellent team effort! Kudos Nurami team! 😎

ICYMI – Read the compelling outcomes in "Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy” published in the Red Journal. Lead author, Dr. Daniel Song, will be presenting more from this study tomorrow at #ASTRO2024 at 2 PM in Session Room 154. https://lnkd.in/gP7tv3M5 #BioProtect #BioProtectBalloon #ProstateCancer #RadiationTherapy #RectalSpacer #SpaceMatters

For my love and support of #Israel and as Co-Chair of MedTech Malta, I dedicate this panel to the successes, ambitions, and uniqueness of The Start-up Nation of Israel. Panel: Israel's Role in Global MedTech Innovation at Lifeblood & MedTech World's MedTech Malta - www.med-tech.world Thank you for joining me on stage to share why the MedTech World needs to be aware of what Israel brings to the table of innovation and investments: 1) Dr. Irit Yaniv, Co-Founder & CEO of Almeda Ventures 2) Gary Gershony, Founding Managing Partner, BayMed Venture Partners 3) Assaf Barnea, Managing Partner of Sanara Capital & Ventures 4) Michal Fisher, VP of Corporate Development at LifeSci Partners 5) Yoav Fisher, Head of Innovation at HealthIL 6) Shai Policker, Managing Partner at EdgeMed 7) Yuval Mandelbaum, CEO of Discure Technologies After Israel being a part of my life for +15 years, I am excited to have these friends and panelists share with the world of MedTech on why it is as special as I have witnessed it to be. Let's congratulate Yuval Mandelbaum for raising a series A of $16M during challenging times beyond the natural challenges of raising capital - it says a great deal about Yuval and his technology: https://lnkd.in/e_mQm5_U For more insights on Israeli MedTech, check out my old Medtech Money Podcast series where we highlighted: * Gur Roshwalb: https://lnkd.in/eQdiZUar * Yoav Fisher: https://lnkd.in/eQjbUqck * Eyal Lifschitz: https://lnkd.in/etPjxNSK * Daniel Adler: https://lnkd.in/eqy8BU7s * Dan Jacob Gelvan: https://lnkd.in/ehcg8RpM * Yotam Drechsler: https://lnkd.in/eQUVJtxD * Ronit Harpaz: https://lnkd.in/eMH6v8Da With love and support of Israel and being able to highlight The Start-up Nation in Malta, Giovanni Lauricella of Lifeblood Check out our new website www.lifeblood.com

When it comes to securing investment, understanding why some investors pass on opportunities is key to refining your approach. Investment mandates, risk tolerance, and differing views on success play significant roles in these decisions. Gaining insight into these factors can help Medtech companies better align their strategies with investor expectations. In our latest LSI Europe '24 panel, "Investors That Pass: An Open Dialogue on Investment Mandates and Definitions of Success," we’ll engage with investors who will openly discuss the factors that lead them to pass on certain opportunities. This panel will provide an inside look at how different investors define success and what truly drives their investment decisions. We’ll hear perspectives from: • Alexei Mlodinow (Moderator) — SIA (Acquired by Integra LifeSciences)) • Diana Saraceni — Panakes Partners • Dr. Irit Yaniv — Almeda Ventures Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with hundreds of global Medtech and Healthtech leaders in Sintra, Portugal. Apply on our website today while space is still available.